1. Long-Acting Formulations of Atypical Antipsychotics

   • Pierre Chue
   • Robin Emsley

   Current Opinion 29 August 2012 Pages: 441 - 448

2. Effect of HMG-CoA Reductase Inhibitors on β-Amyloid Peptide Levels

   • Kina Höglund
   • Kaj Blennow

   Leading Article 29 August 2012 Pages: 449 - 462

   

3. Assessing the Role of Drugs in Suicidal Ideation and Suicidality

   • David M. Reith
   • Liza Edmonds

   Leading Article 29 August 2012 Pages: 463 - 472

4. Mood and Anxiety Disorders in Patients with Myasthenia Gravis

   • Isin Baral Kulaksizoglu

   Therapy In Practice 29 August 2012 Pages: 473 - 481

5. Oral Disease-Modifying Treatments for Multiple Sclerosis

   • Bernd C. Kieseier
   • Heinz Wiendl

   Review Article 29 August 2012 Pages: 483 - 502

   

6. Impact of Psychotropic Medications on Simulated Driving

   • Mark J. Rapoport
   • Melanie C. Baniña

   Review Article 29 August 2012 Pages: 503 - 519

   

7. Selegiline Transdermal System in Major Depressive Disorder

   • James E. Frampton
   • Greg L. Plosker

   Adis Profile Report 29 August 2012 Pages: 521 - 524